CHINA PHARMA HOLDINGS, INC. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
China Pharma Holdings, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • China Pharma Holdings, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 17.9M shares, a 37.8% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 17.9M -10.9M -37.8% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 17.2M +8.71M +103% Jun 30, 2024 10-Q 2024-08-14
Q4 2023 10.6M +9.13M +609% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 28.7M -21.7M -43.1% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 8.45M -40.9M -82.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 8.45M -39.9M -82.5% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 1.5M -3.24M -68.4% Dec 31, 2022 10-K 2024-04-01
Q3 2022 50.4M +3.11M +6.57% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 49.3M +3.73M +8.19% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 48.3M +2.72M +5.97% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 4.73M -40.8M -89.6% Dec 31, 2021 10-K 2023-03-30
Q3 2021 47.3M +3.76M +8.63% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 45.6M +2M +4.59% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 45.6M +2M +4.59% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 45.6M +2M +4.59% Dec 31, 2020 10-K 2022-03-30
Q3 2020 43.6M 0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 43.6M 0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 43.6M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 43.6M 0 0% Dec 31, 2019 10-K 2021-03-26
Q3 2019 43.6M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 43.6M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 43.6M 0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 43.6M 0 0% Dec 31, 2018 10-K 2020-03-30
Q3 2018 43.6M 0 0% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 43.6M 0 0% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 43.6M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 43.6M 0 0% Dec 31, 2017 10-K 2019-03-28
Q3 2017 43.6M 0 0% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 43.6M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 43.6M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 43.6M 0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 43.6M 0 0% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 43.6M 0 0% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 43.6M 0 0% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 43.6M 0 0% Dec 31, 2015 10-K 2017-03-31
Q3 2015 43.6M 0 0% Sep 30, 2015 10-Q/A 2015-12-28
Q2 2015 43.6M Jun 30, 2015 10-Q 2015-08-14
Q1 2015 43.6M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 43.6M 0 0% Dec 31, 2014 10-K 2016-03-30
Q3 2014 43.6M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q1 2014 43.6M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 43.6M 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 43.6M 0 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 43.6M 0 0% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 43.6M +50K +0.12% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 43.6M +50K +0.12% Dec 31, 2012 10-K 2014-03-20
Q3 2012 43.6M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 43.6M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 43.5M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 43.5M Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.